EasyCompare

Relative Intelligence · Pharmaceuticals

How Teva Pharmaceutical Industries (TEVA) compares with the whole market and its popular alternatives

Built by QuantCommons' quantitative engine, this page is about relative opportunity, not data on TEVA alone. It places TEVA (Teva Pharmaceutical Industries Limited) against 19 popular alternatives, its neighboring categories and the entire market of over 10,000 U.S.-listed stocks and ETFs, and surfaces what has done better on consistent outperformance, return for the risk taken, behavior in real market crashes and diversification. The result is a clearer view of where TEVA stands in the market, and of the alternatives worth a closer look.

Period covered: TEVA's full trading record, from October 1986 through September 2026. All returns include reinvested dividends. Data as of October 20, 2026.

Data as of October 20, 2026. Full tables and charts read best on a larger screen.

Rank the market against TEVA →Chart TEVA vs. 19 alternatives →
On this page12 sections

Key findings

How much would $10,000 in TEVA have grown?

This chart tracks a hypothetical $10,000 investment in TEVA over the past 29 years, with dividends reinvested, alongside the same amount in the S&P 500, investments that ended ahead of TEVA over the same span and TEVA's popular alternatives, among those that traded for the entire period. A second view covers the past 5 years, the period the better options further down the page are judged on. It shows not only where each investment ended up but also how smooth or uneven the path was.

Choose a period

From the end of September 1997 to the end of September 2026. The scale is logarithmic, so equal steps up the chart are equal percentage gains. Hover over a fund in the key to pick out its line. 633 of the 1,042 stocks and funds worth at least $500 million that traded the whole period ended ahead of TEVA; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.

$5,000$10,000$20,000$50,000$100,000$200,000$500,000199720022007201220172022$10,000$100,00019972004201120182025
  • COR$574,137+5,641% total · +15.0% a year
  • MCK$208,304+1,983% total · +11.0% a year
  • SPY (S&P 500)$132,907+1,229% total · +9.3% a year
  • CAH$113,257+1,033% total · +8.7% a year
  • NVS$105,143+951% total · +8.5% a year
  • CVS$97,705+877% total · +8.2% a year
  • TEVA$76,156+662% total · +7.3% a year
  • PFE$42,379+324% total · +5.1% a year
  • VTRS$23,883+139% total · +3.0% a year
  • PRGO$13,768+37.7% total · +1.1% a year
Change the dates or add tickers to this chart in EasyCompare

From the end of September 2021 to the end of September 2026. The scale is logarithmic, so equal steps up the chart are equal percentage gains. Hover over a fund in the key to pick out its line. 195 of the 3,628 stocks and funds worth at least $500 million that traded the whole period ended ahead of TEVA; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.

$5,000$10,000$20,000$50,000202120222023202420252026$5,000$10,000$20,000$50,000202120222023202420252026
  • RVMD$74,613+646% total · +49.5% a year
  • KNSA$65,502+555% total · +45.6% a year
  • LLY$52,411+424% total · +39.3% a year
  • CAH$49,682+397% total · +37.8% a year
  • MCK$43,941+339% total · +34.5% a year
  • TEVA$40,657+307% total · +32.4% a year
  • AMRX$37,715+277% total · +30.4% a year
  • COR$26,420+164% total · +21.4% a year
  • SPY (S&P 500)$19,000+90.0% total · +13.7% a year
  • PCRX$4,473−55.3% total · −14.9% a year
Change the dates or add tickers to this chart in EasyCompare

TEVA at a glance

This section summarizes the key facts about the stock, its returns over periods from one to ten years and the risk it has carried, with dividends reinvested throughout. These figures serve as the baseline for every comparison that follows.

The company

Market value
$48B
Industry
Drug Manufacturers - Specialty & Generic
Price history from
October 1986

Returns

Past 1 year
+110%total return
Past 3 years
+403%+71.3% a year
Past 5 years
+303%+32.2% a year
Past 10 years
−3.6%−0.4% a year
Best calendar year
+111%2024
Worst calendar year
−45.9%2017
Losing years
14 of 29full calendar years

Risk

Volatility
42.8%typical yearly swing, 5 years
Sharpe ratio
0.86return per unit of risk, 5 years
Worst decline ever
−90.8%Jul 2015 to Aug 2019
From its all-time high
−39.0%below the peak

TEVA against the whole market

Where TEVA ranks among every stock and fund, and what across the market has done better.

How does TEVA rank among all stocks?

This section ranks TEVA on return, volatility, risk-adjusted return and worst decline against every stock worth at least $300 million with enough history. Where the comparisons with its popular alternatives show how TEVA stacks up against its peers, these rankings show where it stands in the market as a whole.

Ranked against U.S.-listed stocks worth at least $300M that have enough history for each measure, so the count changes from row to row; smaller stocks are left out. Lower volatility and smaller declines rank higher.

MeasureTEVARankStanding
1-year return+110%146 of 3,287top 4%
3-year return+403%145 of 3,017top 5%
5-year return+303%166 of 2,893top 6%
10-year return−3.6%1,841 of 2,202bottom 17%
Volatility, 5 years42.8%1,598 of 2,893bottom 46%
Sharpe ratio, 5 years0.86215 of 2,893top 7%
Worst decline, past 10 years−85.5%1,800 of 2,187bottom 19%

What has beaten TEVA on both return and risk?

Each dot is an investment, placed by how much it earned a year over the past 5 years (higher is better) and how much its price swung, its volatility (further left is calmer). TEVA sits where the dashed lines cross. Anything in the green box above and to the left earned more than TEVA with smaller swings, a better trade-off over this period on both counts. Past results are no promise, but a name in the box is worth a closer look.

Annual return is the annualized total return with dividends reinvested, and volatility the annualized swing in daily prices, both over 5 years. Labeled dots are the strongest picks from the table below and the names called out above, colored by how close they sit to TEVA; faint dots are 28 more of the 37 in the green region (the strongest, one per fund family). 3,633 stocks and funds worth at least $500 million were screened. Hover over a dot for its figures.

−10.0%0.0%10.0%20.0%30.0%40.0%50.0%60.0%70.0%−10.0%0.0%10.0%20.0%30.0%40.0%50.0%60.0%Volatility over 5 years (annualized)Annual return over 5 yearsMore return, less volatility than TEVAVLO: +44.2% a year, volatility 36.9%PSX: +33.2% a year, volatility 32.9%DHT: +38.7% a year, volatility 39.0%ESLT: +39.8% a year, volatility 34.6%EME: +43.0% a year, volatility 35.3%HWM: +47.3% a year, volatility 32.5%MUFG: +33.2% a year, volatility 29.4%BBVA: +38.7% a year, volatility 33.3%IBKR: +35.4% a year, volatility 35.4%MFG: +33.6% a year, volatility 30.6%SMFG: +33.7% a year, volatility 29.4%PWR: +39.3% a year, volatility 37.2%IMO: +34.3% a year, volatility 32.0%JBL: +35.8% a year, volatility 39.6%SBS: +39.1% a year, volatility 37.1%NVT: +35.4% a year, volatility 38.0%COKE: +41.2% a year, volatility 38.0%MLI: +38.9% a year, volatility 33.4%MOG-A: +36.6% a year, volatility 32.0%IDCC: +39.0% a year, volatility 36.9%LAUR: +37.5% a year, volatility 32.8%USLM: +35.6% a year, volatility 36.1%EZPW: +33.2% a year, volatility 35.4%NRP: +37.4% a year, volatility 33.9%ODC: +35.9% a year, volatility 36.9%GE: +36.0% a year, volatility 31.0%TRGP: +41.8% a year, volatility 31.7%CAAP: +35.1% a year, volatility 35.9%TEVA: +32.2% a year, volatility 42.8%SPY (S&P 500): +12.7% a year, volatility 17.1%CAH: +42.1% a year, volatility 24.7%MCK: +38.7% a year, volatility 25.0%CVS: +5.3% a year, volatility 30.4%PFE: −1.7% a year, volatility 25.4%LLY: +40.7% a year, volatility 32.8%RVMD: +48.8% a year, volatility 62.1%KNSA: +50.2% a year, volatility 53.7%JNJ: +12.7% a year, volatility 17.9%MRK: +16.3% a year, volatility 24.8%AZN: +8.7% a year, volatility 35.7%MPC: +51.2% a year, volatility 33.4%PBR-A: +51.8% a year, volatility 37.5%PBR: +50.3% a year, volatility 37.5%APH: +33.8% a year, volatility 32.2%ASX: +48.8% a year, volatility 43.0%SMH: +33.4% a year, volatility 36.9%NHC: +32.0% a year, volatility 28.5%BIL: +3.7% a year, volatility 0.3%INSW: +56.5% a year, volatility 40.5%TEVASPY (S&P 500)CAHMCKCVSPFELLYRVMDKNSAJNJMRKAZNMPCPBR-AAPHASXSMHNHCBILINSW−20.0%0.0%20.0%40.0%60.0%80.0%−20.0%0.0%20.0%40.0%60.0%Volatility over 5 years (annualized)Annual return over 5 yearsMore return, less volatility than TEVAVLO: +44.2% a year, volatility 36.9%PSX: +33.2% a year, volatility 32.9%DHT: +38.7% a year, volatility 39.0%ESLT: +39.8% a year, volatility 34.6%EME: +43.0% a year, volatility 35.3%HWM: +47.3% a year, volatility 32.5%MUFG: +33.2% a year, volatility 29.4%BBVA: +38.7% a year, volatility 33.3%IBKR: +35.4% a year, volatility 35.4%MFG: +33.6% a year, volatility 30.6%SMFG: +33.7% a year, volatility 29.4%PWR: +39.3% a year, volatility 37.2%IMO: +34.3% a year, volatility 32.0%JBL: +35.8% a year, volatility 39.6%SBS: +39.1% a year, volatility 37.1%NVT: +35.4% a year, volatility 38.0%COKE: +41.2% a year, volatility 38.0%MLI: +38.9% a year, volatility 33.4%MOG-A: +36.6% a year, volatility 32.0%IDCC: +39.0% a year, volatility 36.9%LAUR: +37.5% a year, volatility 32.8%USLM: +35.6% a year, volatility 36.1%EZPW: +33.2% a year, volatility 35.4%NRP: +37.4% a year, volatility 33.9%ODC: +35.9% a year, volatility 36.9%GE: +36.0% a year, volatility 31.0%TRGP: +41.8% a year, volatility 31.7%CAAP: +35.1% a year, volatility 35.9%TEVA: +32.2% a year, volatility 42.8%SPY (S&P 500): +12.7% a year, volatility 17.1%CAH: +42.1% a year, volatility 24.7%MCK: +38.7% a year, volatility 25.0%CVS: +5.3% a year, volatility 30.4%PFE: −1.7% a year, volatility 25.4%LLY: +40.7% a year, volatility 32.8%RVMD: +48.8% a year, volatility 62.1%KNSA: +50.2% a year, volatility 53.7%JNJ: +12.7% a year, volatility 17.9%MRK: +16.3% a year, volatility 24.8%AZN: +8.7% a year, volatility 35.7%MPC: +51.2% a year, volatility 33.4%PBR-A: +51.8% a year, volatility 37.5%PBR: +50.3% a year, volatility 37.5%APH: +33.8% a year, volatility 32.2%ASX: +48.8% a year, volatility 43.0%SMH: +33.4% a year, volatility 36.9%NHC: +32.0% a year, volatility 28.5%BIL: +3.7% a year, volatility 0.3%INSW: +56.5% a year, volatility 40.5%TEVASPY (S&P 500)CAHMCKCVSPFELLYRVMDKNSAJNJMPCAPHASXSMHNHCBILINSW
  • Popular alternatives
  • Same and neighboring categories, and shared themes
  • The whole market
  • Others in the green region

Is there a better investment than TEVA?

Investments that beat TEVA over the past 5 years on return, volatility, drawdowns, consistency, crash losses or fees, from its popular alternatives out to the whole market.

How this works

The table below lists investments that beat TEVA over the past 5 years on at least one of these measures: a higher annual return with lower volatility, a higher annual return at similar volatility, a similar return with lower volatility, a higher Sharpe ratio with a smaller worst decline, a higher total return in most periods from 3 months to 10 years, or smaller losses in recent market crashes. It checks TEVA's popular alternatives first, then the rest of its own and neighboring categories, then every stock and fund worth at least $500 million, and shows the strongest few in each group. The full list of those with a higher return and lower volatility than TEVA follows the table.

Annual return is the annualized total return with dividends reinvested. Annual return, volatility and the Sharpe ratio cover 5 years; the worst decline covers the past 10 years. Green marks a better figure than TEVA's. "On the frontier" means no other option shown or tested earned more with less volatility. Funds that hold the same thing are shown once. Beyond the popular alternatives, nothing with more than 1.5× TEVA's volatility counts as better.

These figures cover the past 5 years. Green marks a better figure than TEVA's.

Screen the whole market against TEVA for any period in BetterThanSPYOpen these 19 in EasyCompare
InvestmentWhy it is betterPast 5 yearsDownsideLong runFit
Annual return?higher is betterVolatility?lower is calmerSharpe?return per unit of riskWorst decline?past 10 years10Y returntotalCorr. with TEVA?lower diversifies moreExpenseper year
TEVATeva Pharmaceutical Industries Limited · this page
+32.2%42.8%0.86−85.5%−3.6%1.00—
SPYState Street SPDR S&P 500 ETF · S&P 500
+12.7%17.1%0.79−33.7%+321%0.350.09%
Popular alternativesbest 4 shownThe investments people most often weigh against TEVA. 4 of 19 passed at least one test.
CAHCardinal Health, Inc. · Health Care Distribution
On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst declineSmaller losses in recent crashes+42.1%24.7%1.55−46.1%+349%0.06—
MCKMcKesson Corporation · Health Care Distribution
Higher return, lower volatilityHigher Sharpe, smaller worst decline+38.7%25.0%1.44−38.1%+586%-0.03—
CVSCVS Health Corp. · Managed Health Care
Smaller losses in recent crashes+5.3%30.4%0.32−56.8%+47.0%-0.17—
PFEPfizer Inc. · Pharmaceuticals
Smaller losses in recent crashes−1.7%25.4%0.06−58.9%+55.0%0.16—
Same and neighboring categories, and shared themesbest 6 shownEverything else in Pharmaceuticals and the categories next to it (Biotechnology, Health Care Distribution, Life Sciences Tools, Medical Devices), plus TEVA's specific themes. 19 of 114 passed at least one test.
LLYEli Lilly and Company · Pharmaceuticals
Higher return, lower volatilityHigher Sharpe, smaller worst declineSmaller losses in recent crashes+40.7%32.8%1.21−34.5%+1,807%0.12—
RVMDRevolution Medicines, Inc. · Biotechnology
Higher return in most periods+48.8%62.1%0.95−73.3%—0.33—
KNSAKiniksa Pharmaceuticals International, plc · Biotechnology
Higher return in most periods+50.2%53.7%1.02−83.1%—-0.04—
JNJJohnson & Johnson · Pharmaceuticals
Smaller losses in recent crashes+12.7%17.9%0.76−27.4%+196%0.09—
MRKMerck & Co., Inc. · Pharmaceuticals
Smaller losses in recent crashes+16.3%24.8%0.74−43.4%+241%0.16—
AZNAstraZeneca PLC · Pharmaceuticals
Smaller losses in recent crashes+8.7%35.7%0.41−28.7%+257%0.11—
The whole marketbest 8 shownEvery other stock and fund worth at least $500 million. 817 of 3,500 passed at least one test.
MPCMarathon Petroleum Corporation · Oil & Gas
On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods+51.2%33.4%1.41−79.7%+1,387%0.13—
PBR-APetróleo Brasileiro S.A. - Petrobras · Integrated Oil & Gas
On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods+51.8%37.5%1.31−71.7%+768%0.19—
PBRPetróleo Brasileiro S.A. - Petrobras · Integrated Oil & Gas
Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods+50.3%37.5%1.28−75.3%+674%0.13—
APHAmphenol Corporation · Electronic Components
Higher return, lower volatilityHigher Sharpe, smaller worst declineSmaller losses in recent crashes+33.8%32.2%1.07−37.5%+965%0.29—
ASXASE Technology Holding Co., Ltd. · Semiconductors
Higher return, similar volatilityHigher Sharpe, smaller worst declineHigher return in most periods+48.8%43.0%1.15−52.5%+967%0.24—
SMHVanEck Semiconductor ETF · Semiconductors
Higher return, lower volatilityHigher Sharpe, smaller worst decline+33.4%36.9%0.97−45.3%+1,665%0.280.35%
NHCNational HealthCare Corporation · Medical - Care Facilities
Similar return, lower volatilityHigher Sharpe, smaller worst declineSmaller losses in recent crashes+32.0%28.5%1.12−35.3%+394%0.28—
BILState Street SPDR Bloomberg 1-3 Month T-Bill ETF · Treasury Bonds
On the frontierSmaller losses in recent crashes+3.7%0.3%14.05−0.2%+25.8%0.170.14%
What these numbers mean for TEVA
Annual return
TEVA returned 32.2% a year over the past 5 years with dividends reinvested, against 12.7% a year for the S&P 500. At that pace, $10,000 became about $40,300. Annual return is the steady yearly rate that would produce the same total result, so investments held over the same span compare fairly. Guide: What is performance and return? →
Volatility
TEVA's volatility over the past 5 years was 42.8%, 2.5 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, TEVA's return lands within 42.8% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump. Guide: Understanding and measuring risk (volatility) →
Sharpe ratio
TEVA's Sharpe ratio over the past 5 years was 0.86, against 0.79 for the S&P 500, so TEVA earned more for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings. Guide: Balancing reward with risk (Sharpe ratio) →
Worst decline
TEVA's worst fall from a peak to a low over the past 10 years was 85.5%, against 33.7% for the S&P 500. Losses and gains are not symmetric: climbing back from a 85.5% fall takes a 588% gain. Guide: Market crash risk and tail risk →
Correlation
Over the past 5 years, TEVA's monthly returns had a correlation of 0.35 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They are only loosely linked, which makes it a real diversifier next to an index fund. In the table, the correlation column measures each option against TEVA instead: the lower it is, the more that option would diversify a TEVA holding. Guide: Correlation and diversification →
Show all 37 stocks and funds worth at least $500 million that earned more than TEVA with less volatility

Out of 3,633 tested over 5 years. Best first; funds that hold the same thing are listed once.

#InvestmentFound inAnnual returnVolatilitySharpeWorst decline10Y returnCorr. with TEVAExpense
1
MPCMarathon Petroleum Corporation · Oil & Gas
Whole market+51.2%33.4%1.41−79.7%+1,387%0.13—
2
PBR-APetróleo Brasileiro S.A. - Petrobras · Integrated Oil & Gas
Whole market+51.8%37.5%1.31−71.7%+768%0.19—
3
PBRPetróleo Brasileiro S.A. - Petrobras · Integrated Oil & Gas
Whole market+50.3%37.5%1.28−75.3%+674%0.13—
4
VLOValero Energy Corporation · Oil & Gas
Whole market+44.2%36.9%1.18−71.9%+1,061%0.17—
5
PSXPhillips 66 · Oil & Gas
Whole market+33.2%32.9%1.04−64.2%+430%0.16—
6
CAHCardinal Health, Inc. · Health Care Distribution
Popular alternative+42.1%24.7%1.55−46.1%+349%0.06—
7
APHAmphenol Corporation · Electronic Components
Whole market+33.8%32.2%1.07−37.5%+965%0.29—
8
DHTDHT Holdings, Inc. · Marine Shipping
Whole market+38.7%39.0%1.04−39.7%+1,050%0.02—
9
LLYEli Lilly and Company · Pharmaceuticals
Same or nearby category+40.7%32.8%1.21−34.5%+1,807%0.12—
10
ESLTElbit Systems Ltd. · Aerospace & Defense
Whole market+39.8%34.6%1.15−35.4%+765%-0.08—
11
EMEEMCOR Group, Inc. · Engineering & Construction
Whole market+43.0%35.3%1.20−48.0%+1,202%0.14—
12
HWMHowmet Aerospace Inc. · Aerospace & Defense
Whole market+47.3%32.5%1.36−68.9%+1,028%0.21—
13
MUFGMitsubishi UFJ Financial Group, Inc. · Banks
Whole market+33.2%29.4%1.13−54.9%+483%0.30—
14
INSWInternational Seaways, Inc. · Oil & Gas
Whole market+56.5%40.5%1.31−57.4%—0.14—
15
BBVABanco Bilbao Vizcaya Argentaria, S.A. · Banks
Whole market+38.7%33.3%1.16−69.6%+542%0.30—
16
IBKRInteractive Brokers Group, Inc. · Investment Banking & Brokerage
Whole market+35.4%35.4%1.04−55.1%+935%0.04—
17
MFGMizuho Financial Group, Inc. · Banks
Whole market+33.6%30.6%1.10−45.7%+345%0.23—
18
SMFGSumitomo Mitsui Financial Group, Inc. · Banks
Whole market+33.7%29.4%1.14−47.6%+474%0.35—
19
PWRQuanta Services, Inc. · Engineering & Construction
Whole market+39.3%37.2%1.08−45.5%+2,045%0.20—
20
IMOImperial Oil Limited · Integrated Oil & Gas
Whole market+34.3%32.0%1.09−77.1%+430%0.17—
21
SMHVanEck Semiconductor ETF · Semiconductors
Whole market+33.4%36.9%0.97−45.3%+1,665%0.280.35%
22
JBLJabil Inc. · Electronics Manufacturing
Whole market+35.8%39.6%0.97−57.3%+1,264%0.12—
23
SBSCompanhia de Saneamento Básico do Estado de São Paulo - SABESP · Water Utilities
Whole market+39.1%37.1%1.08−62.0%+293%0.22—
24
NVTnVent Electric plc · Electrical Equipment
Whole market+35.4%38.0%0.99−56.2%—0.25—
25
COKECoca-Cola Consolidated, Inc. · Food & Beverages
Whole market+41.2%38.0%1.10−51.7%+1,569%0.06—
26
MLIMueller Industries, Inc. · Metal Fabrication
Whole market+38.9%33.4%1.16−53.0%+800%0.21—
27
MOG-AMoog Inc. · Aerospace & Defense
Whole market+36.6%32.0%1.14−63.7%+595%0.24—
28
MCKMcKesson Corporation · Health Care Distribution
Popular alternative+38.7%25.0%1.44−38.1%+586%-0.03—
29
IDCCInterDigital, Inc. · Intellectual Property Licensing
Whole market+39.0%36.9%1.08−64.9%+395%0.16—
30
LAURLaureate Education, Inc. · Education Services
Whole market+37.5%32.8%1.14−64.5%—0.19—
31
USLMUnited States Lime & Minerals, Inc. · Construction Materials
Whole market+35.6%36.1%1.03−45.9%+803%0.09—
32
EZPWEZCORP, Inc. · Financial - Credit Services
Whole market+33.2%35.4%0.99−76.6%+202%0.15—
33
NRPNatural Resource Partners L.P. · Coal
Whole market+37.4%33.9%1.11−78.8%+632%0.20—
34
ODCOil-Dri Corporation of America · Chemicals - Specialty
Whole market+35.9%36.9%1.02−48.9%+460%0.21—
35
GEGE Aerospace · Aerospace & Defense
Whole market+36.0%31.0%1.15−80.9%+139%0.16—
36
TRGPTarga Resources Corp. · Oil & Gas Midstream
Whole market+41.8%31.7%1.27−90.8%+829%0.20—
37
CAAPCorporacion America Airports S.A. · Infrastructure
Whole market+35.1%35.9%1.02−89.9%—0.27—

TEVA against its popular alternatives

The investments people most often weigh against TEVA, compared period by period and year by year.

How do TEVA's risk and return compare with its alternatives?

This map plots each investment's annual return over the past 5 years against its volatility, the size of its typical price swings. Investments toward the upper left earned more for a smoother ride, and those toward the lower right earned less for a rougher one. The dashed lines cross at TEVA, which divides the map into what did better or worse on each measure.

Green points earned more than TEVA with less volatility; red points earned less with more. Hover over a point for its figures. Total returns with dividends reinvested, annualized.

10.0%20.0%30.0%40.0%50.0%60.0%−20.0%−10.0%0.0%10.0%20.0%30.0%40.0%50.0%Volatility over 5 years (annualized)Annual return over 5 yearsHigher return, lower volatilityLower return, higher volatilityTEVA: 32.2% a year, volatility 42.8%SPY (S&P 500): 12.7% a year, volatility 17.1%MCK: 38.7% a year, volatility 25.0%CAH: 42.1% a year, volatility 24.7%PCRX: −7.3% a year, volatility 49.4%AMRX: 28.2% a year, volatility 50.5%ANIP: 13.9% a year, volatility 45.5%MNKD: −6.3% a year, volatility 59.5%HRMY: −1.6% a year, volatility 49.3%ALK: −9.7% a year, volatility 43.4%COR: 24.2% a year, volatility 22.8%NVS: 17.2% a year, volatility 20.7%RDY: 1.8% a year, volatility 23.7%PFE: −1.7% a year, volatility 25.4%CVS: 5.3% a year, volatility 30.4%SUPN: 6.6% a year, volatility 35.2%JAZZ: 8.0% a year, volatility 31.5%SNY: 0.6% a year, volatility 25.3%COLL: 1.9% a year, volatility 40.7%PRGO: −14.9% a year, volatility 38.6%VTRS: 10.4% a year, volatility 33.6%TEVASPY (S&P 500)MCKCAHPCRXAMRXANIPMNKDHRMYALKCORNVSRDYPFECVSSUPNJAZZCOLLPRGOVTRS10.0%20.0%30.0%40.0%50.0%60.0%−20.0%−10.0%0.0%10.0%20.0%30.0%40.0%50.0%Volatility over 5 years (annualized)Annual return over 5 yearsHigher return, lower volatilityLower return, higher volatilityTEVA: 32.2% a year, volatility 42.8%SPY (S&P 500): 12.7% a year, volatility 17.1%MCK: 38.7% a year, volatility 25.0%CAH: 42.1% a year, volatility 24.7%PCRX: −7.3% a year, volatility 49.4%AMRX: 28.2% a year, volatility 50.5%ANIP: 13.9% a year, volatility 45.5%MNKD: −6.3% a year, volatility 59.5%HRMY: −1.6% a year, volatility 49.3%ALK: −9.7% a year, volatility 43.4%COR: 24.2% a year, volatility 22.8%NVS: 17.2% a year, volatility 20.7%RDY: 1.8% a year, volatility 23.7%PFE: −1.7% a year, volatility 25.4%CVS: 5.3% a year, volatility 30.4%SUPN: 6.6% a year, volatility 35.2%JAZZ: 8.0% a year, volatility 31.5%SNY: 0.6% a year, volatility 25.3%COLL: 1.9% a year, volatility 40.7%PRGO: −14.9% a year, volatility 38.6%VTRS: 10.4% a year, volatility 33.6%TEVASPY (S&P 500)MCKCAHPCRXAMRXANIPHRMYALKCORNVSRDYPFECVSSUPNJAZZSNYCOLLPRGOVTRS
All figures
InvestmentAnnual returnVolatility
CAH Cardinal Health, Inc.+42.1%24.7%
MCK McKesson Corporation+38.7%25.0%
TEVA This pageTeva Pharmaceutical Industries Limited+32.2%42.8%
AMRX Amneal Pharmaceuticals, Inc.+28.2%50.5%
COR Cencora, Inc.+24.2%22.8%
NVS Novartis AG+17.2%20.7%
ANIP ANI Pharmaceuticals, Inc.+13.9%45.5%
SPY S&P 500State Street SPDR S&P 500 ETF+12.7%17.1%
VTRS Viatris Inc.+10.4%33.6%
JAZZ Jazz Pharmaceuticals plc+8.0%31.5%
SUPN Supernus Pharmaceuticals, Inc.+6.6%35.2%
CVS CVS Health Corp.+5.3%30.4%
COLL Collegium Pharmaceutical, Inc.+1.9%40.7%
RDY Dr. Reddy's Laboratories Limited+1.8%23.7%
SNY Sanofi+0.6%25.3%
HRMY Harmony Biosciences Holdings, Inc.−1.6%49.3%
PFE Pfizer Inc.−1.7%25.4%
MNKD MannKind Corporation−6.3%59.5%
PCRX Pacira BioSciences, Inc.−7.3%49.4%
ALK Alaska Air Group, Inc.−9.7%43.4%
PRGO Perrigo Company plc−14.9%38.6%
Open these 21 in EasyCompare

Has TEVA consistently beaten its popular alternatives?

This section compares TEVA with the investments people most often weigh against it, checking each one over eight periods from one month to ten years. Counting how often an alternative earned more than TEVA helps separate lasting outperformance from a single strong stretch.

A green cell means the alternative earned more than TEVA over that period. "Qualified" marks those that did so in at least 3 of 5 short-term periods and 2 of 3 long-term periods.

InvestmentPeriods outperformed Short termLong termRisk · 5 yearsFund
1M3M6MYTD1Y3Y5Y10YVolatilitylower is calmerSharpehigher is betterWorst declinepast 10 yearsExpenseAssetsOverlapsame sectors
TEVA Teva Pharmaceutical Industries Limited (this page)—+2.0%+31.8%+27.6%+32.0%+110%+403%+303%−3.6%42.8%0.86−85.5%—$48B—
MCK Medical - DistributionMcKesson Corporation1/5 short2/3 long+16.2%+24.0%+20.2%+25.5%+31.3%+131%+413%+586%25.0%1.44−38.1%—$120B—
CAH Medical - DistributionCardinal Health, Inc.1/5 short2/3 long+14.3%+14.3%+22.5%+26.1%+65.3%+191%+479%+349%24.7%1.55−46.1%—$60B—
PCRX Drug Manufacturers - Specialty & GenericPacira BioSciences, Inc.4/5 short1/3 long+50.9%+43.5%+46.1%+48.7%+58.0%+27.6%−31.5%+9.2%49.4%0.11−85.7%—$1.5B—
AMRX Drug Manufacturers - Specialty & GenericAmneal Pharmaceuticals, Inc.2/5 short1/3 long−1.6%+13.4%+49.6%+56.7%+93.8%+472%+247%−9.4%50.5%0.74−94.8%—$6.3B—
COR Medical - DistributionCencora, Inc.1/5 short1/3 long+8.5%+13.1%+6.7%+1.9%+5.7%+86.5%+195%+406%22.8%1.07−32.4%—$66B—
NVS Drug Manufacturers - GeneralNovartis AG1/5 short1/3 long+9.0%+2.7%+1.8%+13.1%+18.8%+75.9%+121%+226%20.7%0.87−26.8%—$292B—
RDY Drug Manufacturers - Specialty & GenericDr. Reddy's Laboratories Limited1/5 short1/3 long+6.9%+6.4%+2.3%−3.4%−9.2%+2.3%+9.0%+59.4%23.7%0.19−40.5%—$11B—
PFE Drug Manufacturers - GeneralPfizer Inc.1/5 short1/3 long+8.5%+23.8%+13.2%+25.7%+30.5%+19.2%−8.3%+55.0%25.4%0.06−58.9%—$172B—
CVS Medical - Healthcare PlansCVS Health Corp.1/5 short1/3 long+8.2%−11.4%+25.6%+21.0%+18.5%+52.5%+29.2%+47.0%30.4%0.32−56.8%—$121B—
SUPN Drug Manufacturers - Specialty & GenericSupernus Pharmaceuticals, Inc.0/5 short1/3 long−3.6%−13.1%−19.6%−16.7%−20.1%+69.6%+37.9%+97.5%35.2%0.36−75.9%—$2.4B—
JAZZ BiotechnologyJazz Pharmaceuticals plc0/5 short1/3 long−11.5%−12.2%+5.5%+23.5%+58.5%+60.1%+46.7%+75.8%31.5%0.40−52.1%—$14B—
SNY Drug Manufacturers - GeneralSanofi0/5 short1/3 long−2.6%−5.9%−10.3%−10.7%−13.4%−10.0%+3.0%+61.5%25.3%0.15−33.5%—$99B—
COLL Drug Manufacturers - Specialty & GenericCollegium Pharmaceutical, Inc.0/5 short1/3 long+0.8%−34.6%−32.3%−49.0%−33.3%+8.2%+9.7%+29.9%40.7%0.25−65.2%—$756M—
ANIP Drug Manufacturers - Specialty & GenericANI Pharmaceuticals, Inc.0/5 short1/3 long−7.8%−6.5%−11.1%−7.3%−23.6%+26.5%+91.9%+8.8%45.5%0.50−73.0%—$1.7B—
MNKD BiotechnologyMannKind Corporation0/5 short1/3 long−11.4%−22.1%+6.2%−44.6%−43.5%−26.4%−27.9%+1.6%59.5%0.19−87.5%—$997M—
PRGO Drug Manufacturers - Specialty & GenericPerrigo Company plc3/5 short0/3 long+14.4%+55.8%+40.7%+24.7%−18.4%−35.6%−55.5%−75.3%38.6%-0.23−87.6%—$2.2B—
VTRS Drug Manufacturers - Specialty & GenericViatris Inc.2/5 short0/3 long+9.1%+10.6%+27.3%+53.1%+87.1%+127%+64.3%−38.0%33.6%0.47−82.0%—$21B—
HRMY BiotechnologyHarmony Biosciences Holdings, Inc.1/5 short0/3 long−8.1%+15.5%+31.1%+3.5%+48.7%+92.3%−7.8%—49.3%0.22−68.5%—$2.3B—
ALK Airlines, Airports & Air ServicesAlaska Air Group, Inc.0/5 short0/3 long−18.0%−25.4%−21.1%−33.3%−29.2%+7.3%−40.0%−51.2%43.4%-0.02−75.1%—$3.8B—
Open these 20 in EasyCompare

How did TEVA do year by year?

This table shows each investment's total return in every full calendar year since 1997, along with where TEVA ranked among its popular alternatives each year. Annual results reveal how consistently each one kept pace with TEVA and how far its good and bad years diverged, detail that multiyear averages tend to smooth over.

Newest year first. Green marks a year in which the fund came out ahead of TEVA; gray means the two finished within a fraction of a point. The rank row places TEVA among the alternatives that traded the full year; dark green is the top quarter and red the bottom quarter.

InvestmentYears ahead of TEVA20252024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997
TEVA This pageTeva Pharmaceutical Industries Limited—+41.6%+111%+14.5%+13.9%−17.0%−1.5%−36.4%−18.6%−46.0%−43.2%+16.7%+47.4%+10.9%−5.1%−21.0%−5.9%+33.6%−7.4%+50.9%−27.1%+45.2%+6.1%+47.8%+26.1%−15.5%+105%+77.0%−13.4%−5.3%
Rank among alternativesTop quarter in 10 of 299 of 201 of 209 of 209 of 2018 of 2012 of 1918 of 1912 of 1919 of 1915 of 195 of 184 of 1817 of 1815 of 1714 of 1614 of 168 of 154 of 152 of 1414 of 142 of 147 of 133 of 131 of 129 of 113 of 101 of 109 of 1010 of 10
SPY S&P 500State Street SPDR S&P 500 ETF16 of 29+17.7%+24.9%+26.2%−18.2%+28.7%+18.3%+31.2%−4.6%+21.7%+12.0%+1.2%+13.5%+32.3%+16.0%+1.9%+15.1%+26.4%−36.8%+5.1%+15.9%+4.8%+10.7%+28.2%−21.6%−11.7%−9.8%+20.4%+28.7%+33.5%
MCK McKesson Corporation18 of 29+44.5%+23.7%+24.1%+51.8%+44.2%+27.1%+26.7%−28.4%+12.0%−28.3%−4.5%+29.3%+67.7%+25.6%+11.8%+13.8%+62.9%−40.4%+29.7%−1.2%+64.9%−1.4%+19.9%−27.2%+4.9%+61.2%−71.3%+46.9%+96.3%
CAH Cardinal Health, Inc.17 of 29+76.3%+19.0%+34.1%+54.1%−0.4%+10.1%+18.0%−24.5%−12.7%−17.5%+12.6%+23.0%+66.0%+3.8%+8.1%+21.4%−4.4%−39.6%−9.8%−5.8%+18.7%−4.7%+3.5%−8.3%−2.5%+108%−36.8%+51.7%+29.1%
PCRX Pacira BioSciences, Inc.8 of 14+37.4%−44.2%−12.6%−35.8%+0.5%+32.1%+5.3%−5.8%+41.3%−57.9%−13.4%+54.2%+229%+102%———————————————
AMRX Amneal Pharmaceuticals, Inc.9 of 16+59.1%+30.5%+205%−58.5%+4.8%−5.2%−64.4%−18.7%+25.7%−69.0%+35.0%+26.0%+22.7%+1.6%+0.3%+47.8%—————————————
COR Cencora, Inc.19 of 29+51.5%+10.4%+25.3%+26.3%+38.0%+17.0%+18.2%−16.6%+20.6%−23.3%+16.9%+29.9%+65.3%+17.9%+10.3%+32.4%+48.0%−19.8%+3.3%+8.9%+41.4%+2.5%+5.6%−14.5%+25.8%+233%−53.3%+11.7%+20.8%
NVS Novartis AG17 of 29+46.0%−0.5%+21.1%+6.6%−5.0%+2.2%+29.1%+6.2%+19.8%−11.8%−4.3%+19.4%+32.2%+16.1%+1.5%+12.6%+14.6%−5.4%−3.4%+11.3%+6.0%+12.3%+27.5%+2.1%−17.2%+30.6%−24.1%+21.9%+52.9%
RDY Dr. Reddy's Laboratories Limited14 of 24−10.5%+14.0%+35.5%−20.3%−7.8%+76.8%+8.6%+1.4%−14.1%−1.7%−7.8%+23.9%+24.0%+17.9%−18.2%+53.8%+149%−45.7%+0.7%+69.2%+9.6%−37.0%+63.8%+3.4%—————
PFE Pfizer Inc.14 of 29+0.6%−2.2%−41.3%−10.4%+66.7%+3.4%−6.7%+25.1%+16.1%+4.4%+7.3%+5.4%+26.5%+20.6%+28.8%+0.6%+8.1%−16.9%−8.2%+15.3%−10.6%−22.3%+17.7%−22.2%−12.5%+43.0%−21.5%+68.8%+82.0%
CVS CVS Health Corp.14 of 29+84.3%−40.8%−12.6%−7.6%+54.9%−5.1%+17.3%−7.0%−5.8%−17.8%+2.9%+36.5%+50.4%+20.3%+19.0%+9.1%+13.2%−27.2%+29.4%+17.7%+17.8%+25.7%+45.7%−14.9%−50.4%+51.1%−27.1%+72.6%+55.5%
SUPN Supernus Pharmaceuticals, Inc.8 of 13+37.5%+24.9%−18.9%+22.3%+15.9%+6.1%−28.6%−16.6%+57.8%+87.9%+61.9%+10.1%+5.2%————————————————
JAZZ Jazz Pharmaceuticals plc11 of 18+38.0%+0.1%−22.8%+25.1%−22.8%+10.6%+20.4%−7.9%+23.5%−22.4%−14.1%+29.4%+138%+37.9%+96.3%+150%+308%−86.9%———————————
SNY Sanofi11 of 23+4.9%+1.1%+6.5%+0.5%+7.0%+0.4%+20.5%+6.0%+9.9%−1.2%−3.4%−11.9%+17.1%+36.0%+18.8%−13.4%+28.7%−26.5%+1.0%+7.2%+11.6%+8.2%+26.2%——————
COLL Collegium Pharmaceutical, Inc.7 of 10+61.6%−6.9%+32.7%+24.2%−6.7%−2.7%+19.9%−7.0%+18.6%−43.4%———————————————————
ANIP ANI Pharmaceuticals, Inc.12 of 25+42.8%+0.3%+37.1%−12.7%+58.7%−52.9%+37.0%−30.1%+6.3%+34.3%−20.0%+181%+172%−59.0%−69.5%+13.1%+45.0%−73.5%+36.5%−24.1%−33.4%+32.4%+23.6%−60.6%+13.3%————
MNKD MannKind Corporation8 of 21−11.8%+76.6%−30.9%+20.6%+39.6%+143%+21.7%−54.3%−27.0%−56.1%−72.2%+0.4%+125%−7.6%−69.0%−8.0%+155%−56.9%−51.7%+46.5%−28.5%————————
PRGO Perrigo Company plc12 of 29−42.8%−16.9%−2.5%−9.8%−10.9%−12.0%+35.7%−55.1%+5.5%−42.1%−13.2%+9.2%+47.9%+7.3%+54.2%+59.8%+24.3%−7.2%+104%+17.4%−12.7%+10.7%+30.3%+2.7%+42.7%+3.5%−9.2%−34.1%+46.7%
VTRS Viatris Inc.13 of 29+5.0%+19.7%+2.0%−14.3%−26.2%−6.8%−26.6%−35.2%+10.9%−29.4%−4.1%+29.9%+58.1%+27.9%+1.6%+14.6%+86.4%−29.7%−29.1%+1.1%+14.2%−29.6%+63.5%−6.4%+49.9%+0.7%−19.5%+51.3%+27.1%
HRMY Harmony Biosciences Holdings, Inc.2 of 5+8.8%+6.5%−41.4%+29.2%+17.9%————————————————————————
ALK Alaska Air Group, Inc.17 of 29−22.3%+65.7%−9.0%−17.6%+0.2%−22.8%+13.8%−15.6%−15.9%+12.0%+36.2%+64.7%+71.3%+14.8%+32.5%+64.0%+18.1%+17.1%−36.7%+10.6%+6.6%+22.6%+26.1%−25.5%−2.2%−15.3%−20.6%+14.2%+84.5%
Open these 21 in EasyCompare

Risk and diversification

How TEVA has fallen, how it held up in crashes beside the S&P 500 and its popular alternatives, and what moves independently of it.

What were TEVA's worst declines?

A drawdown is the decline from a peak to the lowest point before a new high. This section presents TEVA's five deepest drawdowns since it began trading in 1986, alongside the S&P 500's return over the same dates, and how long each took to recover. Together, these figures show how much an investor could have lost and how long it took to get back to even.

Green means TEVA fell less than the S&P 500 over the same dates. Based on daily closing prices with dividends reinvested.

DuringTEVA fellS&P 500, same datesPeakLowTime to the lowBack at the peakTime to recover
2015 China and oil sell-off−90.8%+49.1%Jul 2015Aug 20194.1 yearsNot yet—
No named crash−60.0%—Jun 1987Feb 19888 monthsNov 198921 months
No named crash−52.0%+31.8%Jun 1997Jul 199813 monthsDec 199917 months
2011 euro debt crisis−44.0%−0.4%Mar 2010Sep 201118 monthsNov 20143.2 years
No named crash−36.9%+1.7%Feb 1994Jan 199511 monthsApr 19953 months

How did TEVA do in stock market crashes?

This section measures how far TEVA, the S&P 500 and each alternative fell from peak to trough during every major market crash since 2000. A smaller decline means an investment held up better, and comparing results across crashes shows whether that resilience was consistent or a one-off.

Newest crash first. Each figure is the fund's deepest fall within the crash window; green means a smaller fall than TEVA.

InvestmentHeld up better2023 regional bank crisisMar 20232022 bear marketJan 2022Covid crashFeb 2020Late-2018 sell-offSep 2018February 2018 volatility shockFeb 20182015 China and oil sell-offAug 20152011 euro debt crisisJul 20112010 flash crashMay 20102008 financial crisisOct 2007Dot-com bustMar 2000
TEVA This pageTeva Pharmaceutical Industries Limited—−7.4%−34.0%−50.3%−40.1%−10.7%−21.8%−25.8%−2.4%−23.5%−34.7%
SPY S&P 500State Street SPDR S&P 500 ETF8 of 10−3.4%−24.5%−33.7%−19.3%−6.5%−12.8%−17.9%−1.5%−55.2%−47.5%
MCK McKesson Corporation6 of 10−0.9%−10.5%−32.1%−20.7%−6.5%−30.8%−14.2%−3.5%−57.7%−39.4%
CAH Cardinal Health, Inc.8 of 10−3.5%−21.0%−32.1%−25.5%−4.6%−15.9%−17.5%−1.8%−57.9%−36.1%
PCRX Pacira BioSciences, Inc.4 of 7−3.6%−37.2%−44.0%−20.8%−7.0%−46.3%−37.9%———
AMRX Amneal Pharmaceuticals, Inc.3 of 8−12.5%−58.7%−49.7%−44.4%−2.4%−34.4%−28.1%0.0%——
COR Cencora, Inc.7 of 10−2.3%−17.8%−23.8%−24.2%−7.1%−21.4%−14.5%−2.8%−41.9%−29.7%
NVS Novartis AG7 of 10−1.1%−20.4%−25.5%−9.9%−6.6%−30.1%−14.5%−2.6%−41.7%−25.7%
RDY Dr. Reddy's Laboratories Limited6 of 9−1.4%−25.4%−23.9%−10.4%−2.1%−39.2%−18.1%−2.6%−59.3%—
PFE Pfizer Inc.8 of 10−1.8%−24.6%−21.8%−12.3%−8.1%−18.2%−16.1%−1.8%−49.8%−46.0%
CVS CVS Health Corp.8 of 10−4.4%−19.9%−27.3%−22.1%−9.2%−16.9%−14.2%−1.1%−45.3%−62.4%
SUPN Supernus Pharmaceuticals, Inc.4 of 6−7.3%−26.0%−40.7%−38.8%−5.1%−52.1%————
JAZZ Jazz Pharmaceuticals plc6 of 9−4.2%−24.9%−36.2%−31.0%−3.7%−39.9%−21.9%−3.0%−96.6%—
SNY Sanofi6 of 9−0.5%−33.5%−25.2%−9.0%−9.8%−30.2%−20.7%−2.8%−46.6%—
COLL Collegium Pharmaceutical, Inc.3 of 6−7.1%−36.8%−42.0%−24.9%−7.1%−48.2%————
ANIP ANI Pharmaceuticals, Inc.3 of 9−5.3%−50.0%−51.7%−27.2%−4.7%−50.7%−43.6%−3.2%−86.0%—
MNKD MannKind Corporation2 of 9−7.3%−37.9%−46.2%−46.8%−0.8%−84.7%−36.6%−3.9%−83.1%—
PRGO Perrigo Company plc5 of 10−4.1%−22.5%−32.9%−51.3%−6.6%−31.4%−17.6%−3.0%−55.1%−48.2%
VTRS Viatris Inc.4 of 10−6.9%−43.3%−37.3%−32.8%−6.8%−31.9%−32.4%−0.1%−64.4%−47.3%
HRMY Harmony Biosciences Holdings, Inc.1 of 2−4.8%−35.7%————————
ALK Alaska Air Group, Inc.4 of 10−10.4%−35.9%−64.0%−22.9%−2.8%−27.0%−20.2%0.0%−61.7%−58.5%
Open these 21 in EasyCompare

How closely does TEVA move with the S&P 500?

Upside capture measures how much of the S&P 500's gains an investment kept in the months the market rose, and downside capture how much of its losses it took in the months the market fell. An investment that captures more of the gains than the losses has compounded ahead of the market over time. This section compares TEVA with its popular alternatives on both measures, and on beta (how strongly each has moved with the market), over the past 10 years.

Monthly total returns over the past 10 years, measured against SPY. 100% capture or a beta of 1.00 means moving in line with the S&P 500. Green marks a better figure than TEVA's: more upside, less downside or a higher capture ratio. Sorted by capture ratio.

InvestmentUpside captureDownside captureCapture ratioBeta
TEVA This pageTeva Pharmaceutical Industries Limited55%116%0.481.11
MCK McKesson Corporation72%27%2.710.56
CAH Cardinal Health, Inc.71%51%1.400.75
COR Cencora, Inc.80%58%1.390.56
NVS Novartis AG69%64%1.080.49
RDY Dr. Reddy's Laboratories Limited27%26%1.040.38
JAZZ Jazz Pharmaceuticals plc62%78%0.790.64
SNY Sanofi53%74%0.720.46
SUPN Supernus Pharmaceuticals, Inc.78%115%0.670.87
PFE Pfizer Inc.52%81%0.650.54
CVS CVS Health Corp.59%99%0.600.70
MNKD MannKind Corporation121%216%0.561.50
COLL Collegium Pharmaceutical, Inc.58%106%0.550.89
ANIP ANI Pharmaceuticals, Inc.54%101%0.540.82
AMRX Amneal Pharmaceuticals, Inc.93%189%0.491.20
ALK Alaska Air Group, Inc.80%186%0.431.51
VTRS Viatris Inc.74%179%0.411.14
PCRX Pacira BioSciences, Inc.25%71%0.350.64
PRGO Perrigo Company plc22%147%0.150.87
Open these 19 in EasyCompare

What diversifies TEVA?

Correlation measures how closely two investments move together, on a scale from 1 (in lockstep) through 0 (unrelated) to -1 (in opposite directions). This section lists large ETFs and stocks whose returns have had a low correlation with TEVA's. Because such investments tend not to fall at the same time, pairing TEVA with them can reduce a portfolio's overall swings.

Only ETFs with at least $1.0B in assets and stocks worth at least $10B, with a correlation below 0.5 over the past 5 years and a positive return, are included, ranked by Sharpe ratio; funds that hold the same thing are shown once. The year columns are the years in which TEVA lost money. The last two columns show a portfolio that is 80% TEVA and 20% the other investment, rebalanced monthly.

ETFs

InvestmentCorrelation5Y returnSharpe2021202020192018201720162012201120102008200620011998199780/20 mix volatility80/20 mix annual return
TEVA Teva Pharmaceutical Industries Limited (this page)1.00+303%0.86−17.0%−1.5%−36.4%−18.6%−46.0%−43.2%−5.1%−21.0%−5.9%−7.4%−27.1%−15.5%−13.4%−5.3%39.6%+32.4%
LVHI InternationalFranklin International Low Volatility High Dividend Index ETF0.37+119%1.48+17.8%−9.0%+17.8%−5.2%+10.0%—————————32.4%+30.4%
DXJ InternationalWisdomTree Japan Hedged Equity Fund0.38+225%1.34+18.0%+3.9%+18.9%−19.8%+22.8%+1.1%+19.6%−16.1%−1.8%−20.8%————32.7%+32.6%
EMLP Broad MarketFirst Trust North American Energy Infrastructure Fund0.18+101%1.04+23.1%−13.4%+23.4%−8.7%+1.1%+29.8%————————32.3%+30.3%
HDV Dividend & IncomeiShares Core High Dividend ETF0.27+83.3%1.00+19.6%−6.5%+20.1%−3.0%+13.5%+15.9%+9.6%———————32.6%+29.4%
SMH TechnologyVanEck Semiconductor ETF0.28+323%0.97+42.1%+55.5%+64.5%−9.1%+38.5%+35.6%+8.6%+6.8%+19.0%−44.7%−6.7%−14.6%——34.3%+35.4%
DBEF InternationalXtrackers MSCI EAFE Hedged Equity ETF0.36+85.0%0.96+19.6%+2.1%+24.9%−9.5%+16.7%+6.3%+20.9%———————32.6%+29.7%
GLD CommoditiesSPDR Gold Shares0.05+126%0.96−4.2%+24.8%+17.9%−1.9%+12.8%+8.0%+6.6%+9.6%+29.3%+4.9%+22.6%———32.1%+31.2%
SPMO Broad MarketInvesco S&P 500 Momentum ETF0.32+136%0.93+22.7%+28.2%+25.9%−0.9%+27.8%+7.4%————————33.2%+31.6%

Stocks

InvestmentCorrelation5Y returnSharpe2021202020192018201720162012201120102008200620011998199780/20 mix volatility80/20 mix annual return
TEVA Teva Pharmaceutical Industries Limited (this page)1.00+303%0.86−17.0%−1.5%−36.4%−18.6%−46.0%−43.2%−5.1%−21.0%−5.9%−7.4%−27.1%−15.5%−13.4%−5.3%39.6%+32.4%
CAH Medical - DistributionCardinal Health, Inc.0.06+479%1.55−0.4%+10.1%+18.0%−24.5%−12.7%−17.5%+3.8%+8.1%+21.4%−39.6%−5.8%−2.5%+51.7%+29.1%32.4%+35.5%
CLS Hardware, Equipment & PartsCelestica Inc.0.21+3,143%1.47+37.9%−2.4%−5.7%−16.3%−11.6%+7.4%+11.2%−24.4%+2.8%−20.5%−26.0%−25.6%——36.0%+49.4%
FIX Engineering & ConstructionComfort Systems USA, Inc.0.11+1,636%1.46+89.0%+6.7%+15.1%+0.8%+32.1%+18.3%+15.7%−17.0%+8.7%−15.2%+38.9%+73.7%−9.5%—33.8%+45.4%
MCK Medical - DistributionMcKesson Corporation-0.03+413%1.44+44.2%+27.1%+26.7%−28.4%+12.0%−28.3%+25.6%+11.8%+13.8%−40.4%−1.2%+4.9%+46.9%+96.3%31.9%+35.0%
MPC Oil & Gas Refining & MarketingMarathon Petroleum Corporation0.13+690%1.41+61.0%−27.4%+6.0%−8.2%+34.8%+0.7%+94.3%———————33.2%+37.6%
Open these 14 in EasyCompare

Common questions

What was TEVA's worst drawdown?

TEVA's deepest decline since it began trading in 1986 was 90.8%, from July 2015 to August 2019. It has not yet climbed back to that peak.

What were TEVA's best and worst years?

Over 29 full calendar years, TEVA's best year was 2024, when it returned 111%. Its worst was 2017, with a return of -45.9%.

Is there a better investment than TEVA?

Among TEVA's popular alternatives, CAH and MCK earned more than TEVA with less volatility over the past 5 years. CAH returned 42.1% a year at 24.7% volatility, against 32.2% a year at 42.8%. Looking beyond its popular alternatives, LLY (pharmaceuticals) earned more than TEVA with less volatility over the past 5 years: 40.7% a year at 32.8% volatility, against 32.2% a year at 42.8%.

Is TEVA more volatile than the S&P 500?

Yes. TEVA's volatility over the past 5 years was 42.8%, 2.5 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, TEVA's return lands within 42.8% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump.

What is TEVA's Sharpe ratio?

TEVA's Sharpe ratio over the past 5 years was 0.86, against 0.79 for the S&P 500, so TEVA earned more for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings.

How correlated is TEVA with the S&P 500?

Over the past 5 years, TEVA's monthly returns had a correlation of 0.35 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They are only loosely linked, which makes it a real diversifier next to an index fund. In the table, the correlation column measures each option against TEVA instead: the lower it is, the more that option would diversify a TEVA holding.

What are the best alternatives to TEVA?

None of the 19 popular alternatives we compared outperformed TEVA in at least 3 of 5 short-term and 2 of 3 long-term timeframes, which says more about TEVA's strength than about its alternatives.

Did TEVA outperform the S&P 500?

TEVA finished ahead of the S&P 500 (SPY) in 13 of 29 full calendar years. In 2025, it returned +41.6%, against +17.7% for the index.

How did TEVA do in stock market crashes?

TEVA fell less than the S&P 500 (SPY) in two of the ten major crashes it has traded through, and further in eight. The clearest case was the late-2018 sell-off, when TEVA fell 40.1% and the S&P 500 fell 19.3%.

What diversifies TEVA?

These had a low correlation with TEVA over the past 5 years and still earned a positive 5-year return: among large ETFs, LVHI (correlation 0.37), DXJ (correlation 0.38) and EMLP (correlation 0.18); among large stocks, CAH (correlation 0.06), CLS (correlation 0.21) and FIX (correlation 0.11). A correlation near zero means the two have moved largely independently.

How we measure

More research

Popular alternatives to TEVA

Other stocks and ETFs